CBI is a central european human therapeutics company in the biotechnology, industry that integrates a molecular biology platform with drug development and commercial expertise in discovering and developing disease therapy.

We are driven by our commitment to cutting-edge science results, striving to develop bioactive molecule treatments with positive impact on patient‘s lives.

Leading experts of our company are specialists in human medicine, pharmacy, molecular biology and veterinary medicine with high expertise skills and excellent R&D experience.

All of our partners who are top European scientists, researchers and health professionals share our vision.